نتایج جستجو برای: cardiac hypertrophy

تعداد نتایج: 305267  

Journal: :Circulation 2002
Giovanni Esposito Antonio Rapacciuolo Sathyamangla V Naga Prasad Hideyuki Takaoka Steven A Thomas Walter J Koch Howard A Rockman

BACKGROUND A long-standing hypothesis has been that hypertrophy is compensatory and by normalizing wall stress acts to maintain normal cardiac function. Epidemiological data, however, have shown that cardiac hypertrophy is associated with increased mortality, thus casting doubt on the validity of this hypothesis. METHODS AND RESULTS To determine whether cardiac hypertrophy is necessary to pre...

2009
Zhouyan Bian Jun Cai Di-fei Shen Li Chen Ling Yan Qizhu Tang Hongliang Li

Cellular repressor of E1A-stimulated genes (CREG) is a secreted glycoprotein of 220 amino acids. It has been proposed that CREG acts as a ligand that enhances differentiation and/or reduces cell proliferation. CREG has been shown previously to attenuate cardiac hypertrophy in vitro. However, such a role has not been determined in vivo. In the present study, we tested the hypothesis that overexp...

2017
Qing Q. Wu Jian Ni Ning Zhang Hai H. Liao Qi Z. Tang Wei Deng

Despite therapeutic advances, heart failure-related mortality rates remain high. Therefore, understanding the pathophysiological mechanisms involved in the remodeling process is crucial for the development of new therapeutic strategies. Andrographolide (Andr), a botanical compound, has potent cardio-protective effects due to its ability to inhibit mitogen-activated protein kinases (MAPKs). Andr...

2017
Fangfang Li Yuan Yuan Ning Zhang Qingqing Wu Jin Li Mengqiao Zhou Zheng Yang Qizhu Tang

Evodiamine, a traditional Chinese herb Evodia rutaecarpa, has been shown its anti-inflammatory and anti-bacterial properties. However, the role of evodiamine in cardiac hypertrophy and its possible molecular mechanisms remain unclear. Therefore, this study aimed to investigate the effect of evodiamine on cardiac hypertrophy and explore the possible mechanisms. Aortic banding (AB) on mice was pe...

Journal: :Circulation 2012
Shukuan Ling Qiao Sun Yuheng Li Luo Zhang Pengfei Zhang Xiaogang Wang Chunyan Tian Qi Li Jinping Song Hongju Liu Guanghan Kan Hongqing Cao Zengming Huang Jielin Nie Yanqiang Bai Shanguang Chen Yinghui Li Fuchu He Lingqiang Zhang Yingxian Li

BACKGROUND Sustained cardiac pressure overload-induced hypertrophy and pathological remodeling frequently leads to heart failure. Casein kinase-2 interacting protein-1 (CKIP-1) has been identified to be an important regulator of cell proliferation, differentiation, and apoptosis. However, the physiological role of CKIP-1 in the heart is unknown. METHODS AND RESULTS The results of echocardiogr...

Background: Clinical evidence points to the effective role of genetic factors and intracellular signaling pathways in physiological cardiac hypertrophy. This study aimed to assess the response of PI3K/mTORc1 signaling pathway in cardiac tissue to resistance training in obese diabetic rats. Materials and Methods: For this purpose, 21 male wistar rats (220±20 g) were obese by 6 weeks high fat di...

2017
Di Zhao Wei Wang Hao Wang Honghai Peng Xiangjuan Liu Weixing Guo Guohai Su Zhuo Zhao

Growing evidence shows that protein kinase D (PKD) plays an important role in the development of pressure overload-induced cardiac hypertrophy. However, the mechanisms involved are not clear. This study tested our hypothesis that PKD might mediate cardiac hypertrophy by negatively regulating autophagy using the technique of PKD knockdown by siRNA. Cardiac hypertrophy was induced in 8-week old m...

Journal: :Circulation 2006
Brian DeBosch Iya Treskov Traian S Lupu Carla Weinheimer Attila Kovacs Michael Courtois Anthony J Muslin

BACKGROUND Postnatal growth of the heart chiefly involves nonproliferative cardiomyocyte enlargement. Cardiac hypertrophy exists in a "physiological" form that is an adaptive response to long-term exercise training and as a "pathological" form that often is a maladaptive response to provocative stimuli such as hypertension and aortic valvular stenosis. A signaling cascade that includes the prot...

2013
Yasutomi Higashikuni Kimie Tanaka Megumi Kato Osamu Nureki Yasunobu Hirata Ryozo Nagai Issei Komuro Masataka Sata

BACKGROUND Inflammation is induced in the heart during the development of cardiac hypertrophy. The initiating mechanisms and the role of inflammation in cardiac hypertrophy, however, remain unclear. Toll-like receptor-2 (TLR2) recognizes endogenous molecules that induce noninfectious inflammation. Here, we examined the role of TLR2-mediated inflammation in cardiac hypertrophy. METHODS AND RES...

2017
Lin Cai Guangpu Fan Fang Wang Si Liu Tiewei Li Xiangfeng Cong Jerold Chun Xi Chen

Background: We previously reported that lysophosphatidic acid (LPA) promoted cardiomyocyte hypertrophy in vitro via one of its G protein-coupled receptor subtypes, LPA3. In this study, we examined the role of LPA3 in cardiac hypertrophy induced by isoproterenol (ISO) and myocardial infarction. Methods:In vitro, neonatal rat cardiomyocytes (NRCMs) were subjected to LPA3 knocked-down, or pretreat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید